tradingkey.logo
tradingkey.logo

LeMaitre Vascular Inc

LMAT
View Detailed Chart
109.990USD
+2.130+1.97%
Close 03/24, 16:00ETQuotes delayed by 15 min
1.67BMarket Cap
43.13P/E TTM

LeMaitre Vascular Inc

109.990
+2.130+1.97%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.97%

5 Days

-2.00%

1 Month

+21.20%

6 Months

+25.27%

Year to Date

+35.62%

1 Year

+27.79%

View Detailed Chart

Key Insights

LeMaitre Vascular Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 4 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 110.50.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

LeMaitre Vascular Inc's Score

Industry at a Glance

Industry Ranking
4 / 209
Overall Ranking
43 / 4546
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

LeMaitre Vascular Inc Highlights

StrengthsRisks
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 29.00% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 249.60M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.
Fairly Valued
The company’s latest PE is 42.29, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 21.55M shares, decreasing 4.86% quarter-over-quarter.
Held by Joel Greenblatt
Star Investor Joel Greenblatt holds 16.03K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.42.

Analyst Rating

Based on 9 analysts
Buy
Current Rating
110.500
Target Price
+3.94%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

LeMaitre Vascular Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

LeMaitre Vascular Inc Info

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
Ticker SymbolLMAT
CompanyLeMaitre Vascular Inc
CEOLemaitre (George W)
Websitehttps://www.lemaitre.com/
KeyAI